investiment.io
CERo Therapeutics Holdings, Inc.
$0.05
-0.01 (-9.98%)
CERo Therapeutics Holdings, Inc.
$0.05
-0.01 (-9.98%)
CERO Price Chart
| Basic | |
|---|---|
| Market Cap | $8.72M |
| Price | $0.05 |
| 52 Week Range | 0.0563-12.8 |
| Beta | -0.46 |
| Margins | |
| Gross Profit Margin | 0.00% |
| Operating Profit Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Valuation (TTM) | |
| P/E Ratio | -0.27 |
| Price to Sales Ratio | 0.00 |
| Price to Book Ratio | -0.68 |
| PEG Ratio | 0.04 |
Industry
Biotechnology
Sector
Healthcare
Full-Time Employees
8
Website
IPO Date
2021-11-30T00:00:00.000Z
Description
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.
Phone
650-407-2376
Address
201 Haskins Way, South San Francisco, CA, 94080, US
CIK
0001870404